Healthcare — Earnings Quality Screening

58 Healthcare stocks screened with 18 forensic accounting checks

Grade Distribution

A: 5
C: 5
D: 4
F: 42
A5Strong — minimal red flags
B2Good — generally healthy
C5Fair — some red flags
D4Weak — significant concerns
F42Fail — major red flags

Earnings Quality Characteristics in Healthcare

Healthcare is a sector where earnings quality analysis must account for extremely lumpy economics driven by R&D cycles, patent cliffs, and regulatory milestones. A pharmaceutical company may report strong revenue today while facing a patent expiration that will wipe out 40% of sales within two years — a risk that standard income statements do not surface. Biotech firms often grow almost entirely through acquisitions, layering massive goodwill and in-process R&D onto their balance sheets, which may or may not generate returns. FDA approval milestones create step-function revenue events that distort year-over-year comparisons. Medical device companies face their own issues: aggressive capitalization of device development costs and creative revenue recognition on bundled service contracts. Our screening found that 42 out of 58 healthcare stocks received an F grade, largely because R&D-heavy companies naturally trigger checks related to soft asset accumulation, cash flow divergence from reported earnings, and volatile operating margins. Investors should pay special attention to how healthcare companies account for acquired intangibles and whether cash flow from operations can sustainably cover both R&D spending and shareholder returns.

Common Red Flags in Healthcare

  • Goodwill and acquired intangibles exceeding 50% of total assets, signaling acquisition-dependent growth with impairment risk
  • Operating cash flow persistently trailing net income due to large non-cash gains from fair-value adjustments on acquired assets
  • Revenue concentration in products approaching patent expiration, creating cliff risk not visible in current-year results
  • R&D expense declining as a percentage of revenue — potentially sacrificing pipeline for short-term margin improvement

All 58 Healthcare Stocks

Understand Our Methodology

Every stock undergoes 18 systematic checks based on forensic accounting principles, including Beneish M-Score and Altman Z-Score quantitative models.

View Full Methodology →

Browse by Grade

Featured Reports

Other Sectors

Healthcare Earnings Quality — 58 Stocks | EarningsGrade